Publication
Adjuvant immunotherapy in resectable non-small cell lung cancer with nodal downstaging.
Mengzhen You, Yang Pan, Cien Sun, Li Fu, Jiajing Sun, Yalun Li, Enguo Chen, Jianfei Shen, Jian Zeng, Feng Li
Lung cancer (Amsterdam, Netherlands)Oct 1, 2026PMID 42691831doi:10.1016/j.lungcan.2026.109601 Journal ArticleMulticenter StudypubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
OBJECTIVES: To determine whether prognosis after neoadjuvant chemo-immunotherapy is better predicted by pretreatment clinical nodal stage or post-treatment pathological nodal status, and whether patients downstaged to ypN0 have outcomes comparable to those with primary N0. METHODS: We conducted a…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Lung Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.